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Noncoding RNAs (ncRNAs) function with associated
proteins to effect complex structural and regula-
tory outcomes. To reveal the composition and dy-
namicsofspecificnoncodingRNA-proteincomplexes
(RNPs) in vivo, we developed comprehensive identifi-
cation of RNAbinding proteins bymass spectrometry
(ChIRP-MS). ChIRP-MS analysis of four ncRNAs
captures key protein interactors, including a U1-spe-
cific link to the 30 RNA processing machinery. Xist,
an essential lncRNA for X chromosome inactivation
(XCI), interacts with 81 proteins from chromatin
modification, nuclear matrix, and RNA remodeling
pathways. The Xist RNA-protein particle assembles
in two steps coupled with the transition from pluripo-
tency to differentiation. Specific interactors include
HnrnpK, which participates in Xist-mediated gene
silencing and histone modifications but not Xist
localization, and Drosophila Split ends homolog
Spen, which interacts via the A-repeat domain of
Xist and is required for gene silencing. Thus, Xist
lncRNA engages with proteins in a modular and
developmentally controlled manner to coordinate
chromatin spreading and silencing.INTRODUCTION
Many long noncoding RNAs (lncRNAs) are recently recognized
as functional regulators of gene expression (Rinn and Chang,
2012), but their mechanisms of action are largely unknown.
RNA binding proteins (RBPs) play key roles in lncRNA-mediated
gene regulation, and obtaining the full interactionmap of proteins
bound to a lncRNA of interest is critical to our understanding of
its function. Many tools have been developed to describe
RNA-protein interaction from a protein-centric view, typically
by immunoprecipitating a protein and analyzing the associated
RNAs with a microarray or high-throughput sequencing (re-
viewed by Riley and Steitz, 2013). In contrast, fewer methods
are available from the perspective of a particular RNA. This is
usually achieved by (1) tagging the RNA with affinity aptamers,404 Cell 161, 404–416, April 9, 2015 ª2015 Elsevier Inc.which involves complicated genetic engineering; (2) using in-vi-
tro-transcribed RNA to retrieve proteins from native cell lysates
(RNA chromatography), which is prone to the formation of non-
physiological RNA-protein interactions; and (3) using immobi-
lized oligonucleotides to capture RNA:protein complex under
native conditions, which suffers from both post-lysis re-associa-
tions and unpredictable specificity of target RNA retrieval (re-
viewed by Chu et al., 2015). The ideal strategy should capture
in vivo lncRNA-protein interactions, achieve high yield and spec-
ificity without genetic tagging, and provide comprehensive por-
traits of lncRNP in diverse biological states.
Xist is a lncRNA (17 kb long in the mouse) required for X chro-
mosome inactivation (XCI) of one of the two X chromosomes in
female cells, thus enabling dosage compensation between XX
females and XY males (Gendrel and Heard, 2011). XCI takes
place early in embryonic development and is thought to occur
in multiple steps: counting and choosing the X chromosome to
silence, spreading of Xist over the target X chromosome, and
silencing of most of its active genes (Payer and Lee, 2008). The
latter two steps are believed to be mediated by specific Xist-
associated protein factors, which remain largely mysterious.
Xist expression marks the future inactive X chromosome (Xi)
and is sufficient to recruit silencing chromatin modification com-
plex such as the Polycombproteins (Gendrel andHeard, 2011). It
has been debated whether Xist RNA physically recruits one or
more silencing factors or whether Xist indirectly promotes tran-
scriptional silencing via reinforcement of repressive chromatin.
XCI is also developmentally regulated in several important
ways. In the mouse, XCI can proceed by random inactivation
of either paternal or maternal chromosome in somatic cells or
by always inactivating the paternally derived X in extra-embry-
onic cells, a process called imprinted XCI (Takagi and Sasaki,
1975). During random XCI, Xist is not expressed in pluripotent
embryonic stem cells (ESCs) and is upregulated during differen-
tiation (Wutz and Jaenisch, 2000). Ectopic Xist RNA coating can
induce gene silencing in ESCs, although this is reversible during
an early differentiation time window, becoming irreversible at
later stages (Wutz and Jaenisch, 2000). Knowledge of the Xist
lncRNP in these diverse states may provide insights into this
classic and intricate epigenetic system.
Here, we introduce comprehensive identification of RBPs by
mass spectrometry (ChIRP-MS), an optimized method for the
identification of lncRNA-bound proteome. Applying ChIRP-MS
to four noncoding RNAs, we found known and validated novel
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Figure 1. ChIRP-MS Method and Validation
(A) Outline of the ChIRP-MSworkflow. Briefly, RNP
complexes are crosslinked in vivo by 3% formal-
dehyde for 30 min and solubilized by sonication.
Target ncRNA are pulled out by biotinylated anti-
sense oligos, and associated proteins are eluted
with free biotin, separated by electrophoresis.
Each size fraction is subjected to LC/MS-MS
identification.
(B) Distribution of input and U1- and U2-enriched
RNA sizes, as determined by Bioanalyzer (Agilent).
(C) Proteins retrieved by U1, U2, U3, and control
probes, analyzed by immunoblotting. Arrow in-
dicates the U1A close homolog, U2B, cross-
identified by U1A antibody.
(D) Proteins retrieved by U1, U2, non-targeting
probe control, and Rnase-treated controls, visu-
alized by silver staining. Major proteins enriched
are indicated on the left.functional interactors. By performing Xist ChIRP-MS in different
cell states, lineages, and cell types and with mutant Xist alleles,
we uncover mechanisms of dynamic and coordinate assembly
of Xist binding partners, suggesting an organizing principle for
lncRNPs.
RESULTS
ChIRP-MS Method
Extending on ChIRP-seq, a method using DNA oligonucleotides
to capture lncRNAs and their genomic DNA binding sites (Chu
et al., 2011), we optimized ChIRP-MS to identify lncRNA-associ-
ated proteins (Figure 1A). We cross-link cells extensively with
formaldehyde, retrieve target RNA with oligonucleotide hybridi-
zation, and use a gentle biotin-elution to liberate associated
proteins. The enriched proteins were identified by liquid chro-Cell 161, 404–matography-tandem mass spectrometry
(LC-MS/MS). We conducted negative
controls by use of non-interacting con-
trol probes, RNase treatment of lysate
prior to ChIRP, or genetic removal of the
target RNA.
As a proof of principle, we performed
ChIRP-MS of human U1 and U2 snRNAs
in HeLa S3 cells. The snRNAs are ideal
for validating ChIRP-MS because they
are abundant (1 million copies of U1
per cell) (Gesteland and Atkins, 1993)
and the spliceosome composition is well
known (Pomeranz Krummel et al., 2009;
Stark et al., 2001; Zhou et al., 2002).
Furthermore, non-canonical roles of U1
in preventing premature mRNA cleavage
and polyadenylation have been recently
reported (Almada et al., 2013; Berg
et al., 2012; Kaida et al., 2010), implying
potential novel interactors that ChIRP-
MS may discover. We designed anti-sense DNA oligonucleotides targeting U1 and U2 snRNAs,
respectively, in regions previously found to be accessible for
morpholino binding, and as a negative control, we chose a
non-targeting probe that does not bind any human RNA (Berg
et al., 2012; Kaida et al., 2010). While the input RNA spread
over a large size range (due to shearing by sonication) with
distinct tRNA peaks, after ChIRP-enrichment, the two snRNAs
predominated (Figure 1B). U1 probe retrieved the known direct
binding protein U1A, whereas the control probe did not. U2
probe also enriched for U1A, although the indirect interaction re-
sulted in reduced enrichment. U2 probe also retrieved known
U2-binding protein U2B, which cross-reacts with U1A antibody
due to their close homology (arrow, Figure 1C). ChIRP of U3,
an abundant small nucleolar RNA not involved in splicing, specif-
ically retrieved the nucleolar protein fibrillarin, but not U1A
(Figure 1C). Beta-actin (ACTB) was not enriched by any probe,416, April 9, 2015 ª2015 Elsevier Inc. 405
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serving as another negative control. These results indicate that
ChIRP is specific even for very abundant RBPs.U1 and U2 ChIRP-MS Reveal Known and Novel
Interactors
We next scaled up experiments for MS-level analysis, including
both RNase and non-targeting probe controls. Silver staining of
ChIRP samples showed that U1 and U2 probes pulled down
rich proteins from HeLa lysates, whereas all control samples
are clean (Figure 1D), indicating that ChIRP-MS is highly spe-
cific on the proteome level. U1 and U2 ChIRP-MS enriched
(by >log23.5 or >10-fold, see Experimental Procedures) more
than 400 proteins over respective negative controls (Figure 2A,
full peptide count list in Table S1). The results were highly
reproducible regardless of control strategies: for U1, 98% over-
lap between RNase and non-targeting probe controls; 99%
for U2. The near-identical results from using two orthogonal
methods for background removal highlight the robustness of
the protocol.
U1 and U2 snRNAs shared their RBPs extensively (309 in
common, or 74% of U1 and 84% of U2-RBPs), as predicted
from their common cellular function (Figure 2A). Both U1 and
U2 strongly enriched for proteins involved in splicing and pre-
mRNA biogenesis, as anticipated (Figure S1A). Together, the
two snRNAs retrieved 79% of the human spliceosome compo-
nents (Figure 2A) and 8 of 9 direct U1 binding proteins verified
by crystal structure (Pomeranz Krummel et al., 2009; Stark
et al., 2001; Ruepp et al., 2008). Analysis of known protein-
protein interaction networks showed that the vast majority
(96%) of all proteins identified were within two degrees of
separations from the core spliceosome (Figure 2B) or the direct
binding proteins of U1 (Figure S2A) (Pomeranz Krummel et al.,
2009; Zhang et al., 2012; Stark et al., 2001), suggesting that
ChIRP-MS yields the immediate and most relevant protein
network. Organization of U1/U2 interactomes into complexes
based on curated protein interaction data confirmed extensive
coverage of the spliceosome, SMN, and cap binding com-
plexes (Figure 2C).
U1 selectively enriched for the CSTF complex involved in
pre-mRNA cleavage and polyadenylation, a recently described
non-canonical function of U1 (Figures 2C and S2B; Gene
Ontology (GO) term ‘‘RNA 30-end processing’’ in Figure S1A)
(Berg et al., 2012; Kaida et al., 2010). Immunoblots validated
U1-selective pull-down of CSTF2 over other snRNAs, which
potentially explains this U1-exclusive function (Figure S1B)
(Berg et al., 2012) and shows that ChIRP is specific for proximal
interactions even within the same complex (e.g., the spliceo-
some). These and other protein complexes discovered repre-
sent a wealth of information for the snRNP community (Figures
2C and S1A).Figure 2. U1/U2 ChIRP-MS
(A) Venn diagram of known spliceosome proteins and proteins pulled down by U
(B) Numbers of U1/U2 pulled-down proteins by their degrees of separation from
randomly simulated set of the same number of proteins pulled down by U1 and
(C) Protein-protein and protein-RNA interaction network of U1/U2 pulled-down pr
groups in top half of the plot, and proteins of unknown affiliation are presented at t
(e.g., Polyadenylation and cleavage, Nop56p) are positioned accordingly.Xist Ribonucleoprotein Complex Purification
We next turned to discover the protein partners of Xist. ChIRP-
MS of Xist represents a substantial challenge in several ways:
(1) Xist is far less abundant than U1 (<2,000 copies per cell
versus 1 million) (Buzin et al., 1994), making it more relevant to
other regulatory lncRNAs; (2) Xist transcript is long and will be
sheared into fragments, requiring a tiling-probe strategy not
necessary for the study of U1/U2; (3) Xist is chromatin and nu-
clear matrix associated and therefore insoluble even by deter-
gent and nuclease extraction (Clemson et al., 1996). Based on
these considerations, we designed 43 probes against themouse
Xist RNA (Table S2). In a female mouse cell line (Neuro2a), we
confirmed that Xist RNA was completely solubilized by sonicat-
ion (data not shown), and over 60% of Xist RNA was selectively
retrieved without enrichment of housekeeping Gapdh mRNA
(Figure 3A).
Xist probes retrieved rich protein analytes compared to the
RNase control (Figure 3B). Themost abundant proteins retrieved
are HnrnpK and U, and M, the first two readily visualizable by
Coomassie blue (Figure 3B). HnrnpU is required for the spread
of Xist RNA across the chromosome in cis (Hasegawa et al.,
2010), thus a positive control. Xist-dependent retrieval of all three
proteins was validated by ChIRP-western, proving that they
are not retrieved by virtue of their sheer abundance; the control
protein beta-actin was not enriched (Figure 3C).Stepwise and Developmentally Regulated Assembly of
Xist RNP
We carefully selected biological systems to perform Xist ChIRP-
MS that represents different stages of Xist-mediated silencing
(Figure 4A). Although Xist is expressed in most differentiated
female cells, it is largely dispensable for the maintenance of
XCI (Brown and Willard, 1994; Csankovszki et al., 1999). To
ensure that we catch Xist ‘‘in action,’’ we chose a male mouse
ESC line that has been genetically engineered to harbor a Xist
cDNA knocked into chromosome 11 (chr11) that is inducible
by doxycycline (dox) (Wutz and Jaenisch, 2000). The exogenous
Xist localizes to chr11 and silences chr11 genes at a long dis-
tance after 4 days of sustained expression and retinoic acid-
induced differentiation (Wutz and Jaenisch, 2000) (Figure 4A,
lanes 1 and 2). Turning on or off Xist transcription with dox
creates an isogenically controlled experiment. Furthermore, the
relatively rapid initiation of Xist silencing ensures synchronicity
among cells, suppressing noise arising from population hetero-
geneity. To study the endogenous Xist lncRNP, we performed
parallel ChIRP-MS in an epiblast stem cell line (EpiSC) (Gillich
et al., 2012). EpiSCs are derived from E5.5–E6.5 epiblasts and
represent cells that have just undergone random XCI (occurring
E5.5) (Hayashi and Surani, 2009; Rastan, 1982; Takagi et al.,
1982) (Figure 4A, lane 3). Finally, we performed Xist ChIRP-MS1 or U2. The number of interactions in each set is given after the set label.
known spliceosome proteins. The dashed line represents the distribution of a
U2 (right axis).
oteins. Proteins belonging to known complexes are organized and annotated in
he bottom. Complexes and proteinsmore strongly enriched by U1 (left in graph)
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Figure 3. Xist ChIRP-MS
(A) >60% of Xist RNA was retrieved from the cell
by ChIRP, while no Gapdh was detected. RNase
treatment eliminates Xist transcripts prior to
pull-down.
(B) Proteins retrieved by Xist and isogenic control
(no Xist) visualized by Coomassie blue staining.
(C) Validation of ChIRP-enriched proteins by
immunoblotting.in trophoblast stem cells (TSCs), where the paternal X chromo-
some is always silenced (Calabrese et al., 2012), a phenomenon
termed imprinted XCI that contrasts with the random XCI in so-
matic cells (Figure 4A, lane 4). RNase controls were performed
side by side in the EpiSC and TSC experiments.
We also compared Xist ChIRP-MS to ChIRP-MS of three
abundant nuclear RNAs—U1, U2, and 7SK—to evaluate Xist-
specific interactions (Experimental Procedures). 7SK is a snRNA
present at200,000 copies per cell and is involved in transcrip-
tional elongation control. We ranked peptides enriched by each
ncRNA and prioritized proteins that had Xist ChIRP-MS enrich-
ment ranking at least 2-fold better than rankings in any of the
three comparator ncRNAs.
In total, we identified 81 Xist binding proteins from the four ex-
periments (Figure 4A and full list of enriched proteins with pep-
tide counts reported in Table S3). When compared to U1/U2/
7SK, only a minority of Xist hits (30/81) was also highly enriched
by another ncRNA (rank ratio < 2, Table S4). These non-specific
proteins are mainly involved in RNA processing (GO enrichment
p = 8.4E28) andmay be involved in nuclear ncRNA splicing, nu-
clear retention, or stability. They are likely bona-fide Xist binding
proteins because they pass RNase and genetic controls, but
they may not contribute to the specific gene regulatory function
of Xist. We provide the list of non-specific proteins retrieved by
all four nuclear ncRNAs as a resource for the field (in red, Table
S4). In contrast, the Xist-specific proteins selectively enriched for
gene repressors (GO enrichment p = 9.6E8), which are high-
lighted in Table S4 and discussed below. We also overlapped
the set of proteins retrieved by Xist with those retrieved by
two other abundant nuclear lncRNAs, NEAT1 and MALAT1,
and found limited overlap (14 out of 81 shared by all three,
Figure S2C) (West et al., 2014). As expected, themajority of over-408 Cell 161, 404–416, April 9, 2015 ª2015 Elsevier Inc.lapping proteins (8/14) are ‘‘nonspecific
ChIRP hits’’ as defined above.
Xist ChIRP-MS in all four cell types
retrieved a common set of proteins (62/
81, 77%), termed Set 1. An additional 19
proteins interacted with Xist only in differ-
entiated ESC, EpiSC, and TSCs; these
proteins are termed Set 2. We describe
the identity of proteins in these two sets
and then discuss the dynamics of the in-
teractions. Some of the binding proteins
were known factors involved in XCI. We
identified Rnf2 (also known as Ring2 or
Ring1b), the catalytic subunit of Poly-
comb repressive complex 1 (PRC1) thatdeposits the repressive lysine119 monoubiquitination on histone
H2A (H2AK119ub) over the inactive X chromosome (de Napoles
et al., 2004; Fang et al., 2004). Other PRC1 components identi-
fied included Pcgf5 and Rybp (both in set 1); Rybp is a stoichio-
metric component of PRC1 that has been shown to accumulate
on the Xi independently of PRC2 (Tavares et al., 2012). We also
found the Sin3-HDAC1 components Spen, Sap18, and
Mybbp1a, which are repressive transcriptional factors that re-
cruit histone deacetylase (HDAC) complexes. Histone deacety-
lation correlates with reduced gene expression and is another
hallmark of the inactive X chromosome (Keohane et al., 1996).
The co-purification of these proteins may bridge the biochemical
gap between Xist and HDAC that remains little explored in the
field. Xist ChIRP-MS also recovered nuclear matrix proteins
HnrnpU, Matrin 3, and Safb, consistent with the observation
that Xist is probably anchored by nuclear matrix (Clemson
et al., 1996). Notably, HnrnpU is required for Xist localization (Ha-
segawa et al., 2010). Finally, RBPs such as HnrnpK strongly and
specifically interacted with Xist; HnrnpK was not retrieved by U1
or U2. Collectively, the two sets of proteins represent candidate
factors that could play roles in Xist localization or function.
Comparison of Xist interactors in the four cell types revealed
a potential step-wise assembly of Xist binding proteins from
the pluripotent state to differentiation. Unsupervised hierarchical
analysis showed that the Xist interactors are distinct in ESCs,
whereas the differentiated ESC, EpiSC, and TSC shared a signif-
icant degree of overlap (Figure 4A). Whereas Set 1 proteins
remain associated with Xist from pluripotency to differentiation,
Xist interaction with Set 2 proteins is observed only upon differ-
entiation. Xist interacted with both Set 1 and Set 2 proteins in the
latter three cell types; 77 of 81 Xist interactors (95%) were
independently retrieved in these differentiated cells. The HDAC
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Figure 4. Xist Partner Proteins Are Develop-
mentally Regulated
(A) Heatmap of Xist-RBPs pulled down in the four
experiments. Color bars indicate abundance of
peptides detected. Protein annotations were color
designated based on their class.
(B andC) (B) Similar proteins are enriched between
differentiating ES cells versus EpiSCs and (C)
between EpiSCs and TSCs.complex subunit Spen straddles these categories because it in-
teracts with Xist in ESC, but the interaction intensifies with differ-
entiation (asterisk in Figure 4A). The distinction between Set 1
and 2 is unlikely due to lower efficiency of Xist ChIRP-MS in
ESCs because the quantitative signal for Set1 proteins in ESC
is on par with that in differentiated cells. While the Set 1 proteins
may represent the ground state of Xist-interactome that pre-
pares the lncRNA for action, the differentiation-coupled Xist in-
teractors include intriguing chromatin-modifying proteins such
as Spen, Rnf20, Mybbp1a, and Sap18. These may represent
additional silencing factors recruited to Xist RNA when XCI is in
full action. Quantitative comparison between Xist ChIRP-MS in
differentiated ESC versus EpiSC or versus TSC showed that
they are largely similar, especially for the strong interactors (r =
0.67 and 0.85, respectively, Figures 4B and 4C). These results
suggest that (1) transgenic Xist indeed phenocopies the endog-
enous RNA and shares similar binding proteins; (2) ChIRP-MS is
robust and gives consistent results in multiple systems; (3)
random XCI and imprinted XCI appear to employ nearly identical
Xist-associated proteins, and therefore, extraembryonic troph-
oectoderm likely executes silencing in ways that are highly
similar to that of the embryo proper.
HrnpK Participates in Xist-Mediated Gene Silencing
To assess the functional importance of Xist-interacting proteins
in gene silencing, we tested their dispensability in Xist-mediated
silencing of the imprinted Grb10/Meg1 gene, previously shown
to be silenced by Xist upon differentiation of ESC (Wutz and Jae-
nisch, 2000). The imprintedGrb10 gene is located 41megabases
away from the Xist transgene on chr11 and is thought to bemono-
allelically expressed from the chr11 harboring the transgene (Fig-
ure 5A) (Wutz and Jaenisch, 2000). We showed it indeed wasCell 161, 404–silenced by transgenic Xist (Figure 5B).
We chose to first target HnrnpK, M, and
U because they represent some of the
most enrichedSet 1 proteins (especially K)
andbecause thissimpleheuristic identifies
HnrnpU, a known key mediator of Xist
function. Upon siRNA-mediated depletion
(Figure 5C), only HnrnpU and HnrnpK had
significant effects onGrb10 silencing (Fig-
ure 5D). We ruled out off-target effects
by showing that all four individual siRNAs
against HnrnpK produced the same de-
repression effect (Figure S4A). We directly
visualized transcription from the Xist-
silenced allele using two-color RNA-FISH(Figures 5E and 5F). We used a genomic (BAC) probe, allowing
us to detect the Grb10 nascent transcript rather than its mature
mRNA. In this way, we scored for the presence or absence of
Grb10 transcription adjacent to the Xist-coated chr11. HnrnpK
depletion significantly increased the frequency of active Grb10
allele found close to or within the Xist RNA-coated chromosome
11, indicating that, indeed, it is less sensitive to Xist-mediated
silencing in the absence of HnrnpK (Figures 5E and 5F).
We also tested the requirement for HnrnpK in endogenous XCI
in EpiSC. We converted ESC into EpiSC in the presence of Fgf2
and Activin (Guo et al., 2009). EpiSC conversion was confirmed
by morphologic changes, marker expression, induction of Xist
expression, and Xist localization to the Xi (Figures S3A–S3D).
We performed single-molecule fluorescent in situ hybridization
(sm-FISH) on Usp9x, an X-linked gene that is subject to random
X-inactivation. We used FISH probes against the introns of
Usp9x gene to exclusively detect its pre-mRNA that indicates
active transcription. Although only 10% of the cells show two
Usp9x pinpoints in control cells, HnrnpK- or HnrnpU-depleted
cells showed a 2- to 3-fold increase in cells with two Usp9x
FISH signals (Figures S3E and S3F). The reduction in successful
XCI for HnrnpU depletion matched observations from a prior
study (Figure S3F) (Hasegawa et al., 2010). We conclude that
HnrnpK is an important factor for Xist-mediated silencing.
HnrnpK Contributes to Xist-Mediated Chromatin
Modifications, but Not Xist Biogenesis or Localization
We tested potential roles of HnrnpK early in the sequence of
repressive events, including Xist biogenesis, localization, and
spreading or chromatin silencing. Northern blot analysis showed
that Xist abundance or splicing were not impacted by depletion
of HnrnpK, U, or M (the two minor isoforms upon HnrnpU416, April 9, 2015 ª2015 Elsevier Inc. 409
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Figure 5. Functional Characterization of
Xist RBPs
(A) Relative positions of Grb10 and Xist transgene
(TG) on chr11.
(B) Induction of Xist and repression of Grb10
by different doses of dox in e36 cells that have
undergone RA-induced differentiation for 4 days.
(C) Western validation of HnrnpU, K, and M
knockdown by siRNAs.
(D) De-repression of Grb10 upon depletion of
HnrnpU, K, and M.
(E) Dual-color FISH of Grb10 and Xist in e36 cells
that are depleted of HnrnpK. Arrowheads indicate
Grb10 allele escaping Xist silencing.
(F) Quantification of cells with Grb10 expression on
the Xist-coated chromosome by counting >150
cells from 3 replicates.depletion are consistent with previous report) (Hasegawa et al.,
2010) (Figure 6A), although we cannot exclude that minor
changes occurred given that Xist is present in multiple isoforms.
Next, sm-FISH confirmed that HnrnpU depletion indeed delocal-
ized Xist, but HnrnpK depletion did not (Figure 6B). Combined
immunofluorescence and RNA FISH (IF-coFISH) showed that,
while Xist RNA colocalized with H2AK119ub and H3K27me3,
HnrnpK depletion significantly reduced the accumulation of
H2AK119ub and H3K27me3 on the Xi without affecting Xist
RNA localization (Figures 6C and 6D). HnrnpK depletion did
not affect the global level of H3K27me3, showing that HnrnpK
has a specific impact on Xist-mediated recruitment of repressive
chromatin marks (Figure S4B). Given that both H3K27me3 and
H2AK119ub modifications are among the earliest epigenetic
changes occurring to the Xi, the results are consistent with our410 Cell 161, 404–416, April 9, 2015 ª2015 Elsevier Inc.hypothesis that HnrnpK is a novel regu-
lator of the initiation of X-inactivation.
Xist ChIRP retrieved multiple PRC1 sub-
units, and PRC1 or PRC2 action can
mutually recruit each other (Blackledge
et al., 2014; Cooper et al., 2014; Kalb
et al., 2014). Indeed, HnrnpK depletion
also spatially dissociated Xist from the
PRC2 subunit Eed (Figure S5). HnrnpK
contains three RNA-binding KH domains
that may directly bind Xist. UV-cross-link-
ing RNP immunoprecipitation followed by
RT-PCR (CLIP-qRT-PCR) showed that
HnrnpK directly bound Xist RNA, with
the strongest interaction mapping down-
stream of repeat F in exon 1 (Figure S4C).
HnrnpK retrieved Xist more efficiently in
CLIP than HnrnpU, a known direct inter-
action that we reproduced (Hasegawa
et al., 2010).
The A-Repeat of Xist Interacts with
Spen to Mediate Gene Silencing
We next explored the use of ChIRP-MS to
dissect domain-specific interactions ofXist with its partner proteins. A small 0.9 kb region on the very
50 end of Xist that harbors the conserved A-repeat element is
required for transcriptional silencing, but not for chromatin inter-
action or spreading across the X chromosome (da Rocha et al.,
2014; Wutz et al., 2002). In principle, deletion of A-repeat may
alter RNA folding or modification to abrogate interaction of
most of the silencing proteins; alternatively, the A-repeat may
be selectively required for the interaction of a small number of
key silencing factors. ChIRP-MS appears to be an ideal
approach to distinguish between these models. Xist ChIRP-MS
of ES cells harboring inducible full-length Xist or A-repeat mutant
at the endogenous locus on the X chromosome (Wutz et al.,
2002) revealed that most protein interactions were not affected
by the deletion, but three proteins—Spen, Rnf20, and Wtap—
were completely unable to bind the mutant (Figure 7A). Notably,
AXist
18s
siCtrl siM siU siK
B
siCtrl siHnrnpU siHnrnpK
Xist DAPI
C
Xi
st
H
3k
27
m
e3
siCtrl siHnrnpK
Xi
st
D
A
PI
H
3k
27
m
e3
Total=205Total=296
siCtrl siHnrnpK
Xi
st
H
2A
K
11
9u
b
Xi
st
D
A
PI
H
2A
K
11
9u
b 
Total=298 Total=261
strong
weak
nil
D
Figure 6. HnrnpK Is Required for Repressive Chromatin Modifications of Inactive X
(A) Northern blot against Xist in e36 cells depleted of HnrnpM, U, or K.
(B) Xist sm-FISH in HnrnpU and K knockdown cells.
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marks overlapping with Xist foci were tallied and represented below.Spen interaction with Xist is increased upon ESC differentiation,
and Rnf20 and Wtap both belong to Set 2 proteins that interact
with Xist only upon differentiation (Figure 4A). Thus, the A-repeat
appears to be a focus of the differentiation-coupled assembly of
Xist RNP. The exclusive binding of these three proteins to full-
length Xist, but not the A-repeat mutant, was confirmed by
ChIRP-western (Figure S6A). This result also implied that HnrnpKbinding does not require A-repeat, which we confirmed by
ChIRP-western (Figure S6A). Thus, two sets of silencing proteins
bind to different domains of Xist.
We reasoned that one or more of the A-repeat binding factors
may be required for XCI. RNAi depletion in ES cells harboring
wild-type Xist of each of these proteins, as well as Rnf40, a func-
tional partner of Rnf20, showed that only depletion of Spen, butCell 161, 404–416, April 9, 2015 ª2015 Elsevier Inc. 411
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not the other proteins, dramatically reduced Xist-mediated
silencing of the X-linked gene Pgk1 (Figure 7B). Rnf20 and
Rnf40 depletion actually slightly increased Pgk1 silencing, which
is consistent with their known roles in enhancing transcription
(Figure 7B) (Zhu et al., 2005). In addition, by two-color RNA-
FISH, we found that Spen depletion results in reduced silencing
of the X-linked genes Mecp2 and Rnf12, with more frequent
detection of nascent transcription from the Xist-coated inactive
X chromosome in Spen-depleted cells compared to control cells
or to cells depleted for Rnf20, Rnf40, or Wtap (Figures 7C and
7D). This experiment further illustrates that Spen is not appar-
ently required for Xist RNA accumulation or spreading across
the Xi but is specifically needed for transcriptional silencing,
which is consistent with its specific association with the A-repeat
region of Xist. Furthermore, we validated the requirement of
Spen for silencing of Grb10 in ESCs, where an Xist transgene
is ectopically expressed on chr11 (Figure S6B). Collectively,
these results suggest that Spen could be a functional mediator
of Xist-RNA-driven gene silencing.
Spen is the mouse homolog of Drosophila homeotic mutant
Split ends and encodes a transcriptional repressor (Arieti et al.,
2014; Shi et al., 2001). Spen contains at least three RNA recog-
nition motifs (RRMs) that can bind the lncRNA SRA to mediate
RNA-directed transcriptional regulation (Arieti et al., 2014; Shi
et al., 2001). Several existing Spen antibodies tested were not
suitable for UV CLIP. Instead, we generated recombinant
Spen RRM domains by in vitro translation and found that two
or three of the Spen RRMs preferentially retrieved with Xist
A-repeat over GFP mRNA in vitro (Figure S6C). These results
suggest that Spen RRM domains may interact directly with the
Xist A-repeat region.
DISCUSSION
ChIRP-MS: An RNA-Centric Interactome Technology
ChIRP-MS provides a potentially universal interactome discov-
ery strategy that can be readily applied to any RNA of interest.
We found comparable results from RNase-treated samples or
isogenic cells that lack the target RNA, suggesting application
in non-genetic systems. The use of different cross-linking re-
agents allows the investigator to potentially tune the degree of
interactions captured from the target RNA. The thorough re-dis-
covery of the spliceosome complex proteins by ChIRP-MS of U1
and U2 snRNPs validates the robustness of ChIRP-MS. In
addition, the novel factors found in U1, U2, and Xist RBPs (func-
tionally validated in the latter) demonstrate the added sensitivity
of ChIRP-MS over traditional methods of RBP identification and
provide a rich resource for future investigations. For example,
U1-specific interaction with the cleavage stimulation and polya-
denylation proteins has direct implications for ‘‘telescripting,’’
a critical process of U1-mediated protection from premature
mRNA shortening (Berg et al., 2012; Kaida et al., 2010).(C) siRNA depletion of Spen interferes with XCI in cells, as indicated by co-localiza
(arrowheads) on the same chromosome.
(D) Quantification of cells with expression of Mecp2 and Rnf12 on the Xist-coate
does not upregulate Xist and does not coat (around 40%); we counted only the
(E) Model of the cell-state- and scaffold-specific loading of Xist-RBPs and their cDynamic Plug-and-Play of Xist Binding Proteins
Our analysis revealed two sets of proteins that interact with Xist
in a developmentally regulated manner. As Xist expression and
reversibility of Xist-mediated gene silencing are tightly coupled
to ESC differentiation, Xist may gain new silencing functions,
perhaps through newly acquired or strengthened protein interac-
tions, upon exit frompluripotency. Consistent with this idea, ‘‘Set
2’’ proteins bind Xist exclusively in differentiating ESCs (and
EpiSCs and TSCs); this developmentally controlled assembly
of Xist RNP provides a fail-safe backup for premature Xist
expression during pluripotency. The expression of most factors
in Set 2 remains stable throughout the differentiation of mESC
into mEpiSC (< 2-fold change), as measured by whole-nucleus
proteomic analysis (Song et al., 2012) (Figure S6D). Thus, the
vast majority of Set 2 interactions are most parsimoniously ex-
plained by a change in Xist RNA that now allows interaction
with a pre-existing set of proteins. In contrast, the compositions
of Xist-RBPs are strikingly similar in differentiating ES cells,
EpiSCs, and TSCs. TSCs are derived from extra-embryonic tro-
phectoderm cells, where the inactive X is always paternal (Takagi
and Sasaki, 1975). It remains a standing debate in the field
whether imprinted XCI differs from random XCI merely by a
simple choice mechanism while sharing the same silencing
machinery or whether the imprinted versus random XCI are
fundamentally different. Our observations support the former
hypothesis and suggest that the difference between random
versus imprinted XCI is focused on the choice mechanism of
the future Xi.
HnrnpU and HnrnpK emerged as themost enriched Xist-asso-
ciated factors, and both functionally contribute to XCI. Although
HnrnpU is required for Xist spreading across X chromosome,
HnrnpK knockdown affects Xist-directed deposition of silencing
histone modifications H2AK119ub and H3K27me3, the products
of PRC1 and PRC2 complexes, respectively. Xist appears to
directly bind PRC1, but not PRC2. This is consistent with recent
reports demonstrating the PRC1-dependent recruitment of
PRC2 complex (Blackledge et al., 2014; Cooper et al., 2014;
Kalb et al., 2014). It has been reported that PRC2 binds specif-
ically to the repeat A (repA) transcript of Xist, which is produced
as a separate and shorter RNA (1.6 kb, including the A-repeat
region) (Zhao et al., 2008), although the exact function of this
shorter transcript remains unclear. One explanation for our find-
ings could be the existence of different RNA isoforms with
different functions. Further tests will be required to dissect the
events by which Polycomb proteins associate with Xi.
Modular Xist RNA Domains Link Spen- and
HnrnpK-Mediated Silencing
Although the A-repeat was proposed to recruit PRC2 complex
(Zhao et al., 2008), PRC2 itself is dispensable for the initiation
of gene silencing during XCI (Kalantry and Magnuson, 2006).
Furthermore, in the A-repeat deletion Xist mutant, PRC2 andtion of Xist ‘‘cloud’’ and active transcription of X-linked genes Rnf12 andMeCP2
d chromosome by counting >100 cells from 3 replicates. A proportion of cells
cells with Xist domains.
hromatin-modifying functions.
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H3K27me3 are still recruited to the Xist-coated chromosome (da
Rocha et al., 2014; Plath et al., 2003). Imaging studies suggested
that Xist RNA create a transcriptionally inactive nuclear compart-
ment, independent of the A-repeat, but that the A-repeat is
required for the movement of genes into this compartment as
they become silenced (Chaumeil et al., 2006). These
observations suggest that factors beyond PRC2 are at play.
Our results revealed the A-repeat—essential for Xist-mediated
gene silencing (Wutz et al., 2002)—as a key element for the
developmentally regulated binding of several proteins. The se-
lective abrogation of three protein interactions but full preserva-
tion of all others by the A-repeat deletion highlights the modular
organization of Xist. We found Spen, a potent transcriptional
repressor, to be important for Xist-mediated silencing. Spen
interaction with Xist is increased upon differentiation, suggesting
a gain of Spen-associated silencing activity to the Xist RNP. The
Spen knockout is embryonic lethal at E12.5 (Kuroda et al., 2003),
which is later than expected if XCI is fully defective. However, the
knockout was not performed with a maternal germline depletion
of the protein, so an earlier phenotype masked by the maternal
pool cannot be ruled out. On the other hand, Spen may well
collaborate with other Xist-recruited silencing activities, and
there may also be potential redundancy with two other mamma-
lian Spit ends homologs.
The reported association between Spen and MBD3-NuRD
complex nominates several gene-silencing pathways, including
ATP-dependent nucleosome remodeling, histone deacetylation
via HDACs, and modulation of DNA methylation (Shi et al.,
2001; Zhang et al., 1999). NuRD complex decommissions ESC
enhancers to enable differentiation and lineage commitment—
the same developmental window where XCI takes place (Rey-
nolds et al., 2012;Whyte et al., 2012). It is conceptually appealing
that the same silencing mechanism that turns off pluripotency
regulators may both enable Xist expression (by removing
repression of Xist) and endow Xist with the silencing power to
achieve XCI. Intriguingly, Spen interacts with Mbd3 (Shi et al.,
2001); NuRD recruitment to active enhancers is believed to occur
through Mbd3 recognition of 5-hydroxymethylcytosine (Yildirim
et al., 2011). NuRD-mediated deacetylation of H3K27ac also
permits PRC2-mediated H3K27me3 and gene silencing (Rey-
nolds et al., 2012). Thus, the combination of NuRD and Poly-
comb activity can turn an active gene into an inactive one. We
propose that Xist may serve as a physical scaffold for organizing
at least two chromatin modification activities— a writer to
deposit silencingmarks via PRC1 and an eraser to remove active
marks via Spen and associated factors—that, together, coordi-
nately enforce permanent epigenetic silencing (Figure 7E).
Although the other two A-repeat associating factors do not
directly impact XCI in our limited analysis, they could conceptu-
ally still contribute to XCI. Rnf20 is the E3 ubiquitin ligase for
H2BK120ub1, a histonemodification that marks the gene bodies
of transcriptionally active genes (Zhu et al., 2005). Xist has been
proposed to preferentially target actively transcribed genes on X
chromosome, exploiting the spatial proximity of actively tran-
scribed loci to efficiently target Xist-associated silencing factors
(Engreitz et al., 2013; Simon et al., 2013). Furthermore, the
A-repeat mutant of Xist shows reduced binding to such active
regions (Engreitz et al., 2013), which may be explained by the414 Cell 161, 404–416, April 9, 2015 ª2015 Elsevier Inc.inability of the Xist A-repeat mutant to seek out Rnf20 complex
loaded on active loci. Finally, Wtap is involved in the installation
of the N6-methyladenosin (m6A) on RNAs. Wtap binding to
the A-repeat of Xist is consistent with the presence of m6A in
the same region of the RNA (data not shown). The functional
impact of Wtap binding or m6A modification remains to be
understood but represents an exciting perspective given the
strategic importance of the domain in question. Our results set
the stage for future structure-function analysis of Xist and its in-
teracting proteins as a paradigm to understand functional motifs
in lncRNAs.
EXPERIMENTAL PROCEDURES
ChIRP-MS
10–20 15 cm dishes of cells were used per ChIRP-MS experiment (100million–
500 million cells, depending on the cell type). Cell harvesting, lysis, disruption,
and ChIRP were essentially performed as previously described (Chu et al.,
2012), with the following modifications: (1) cells are cross-linked in 3% formal-
dehyde for 30min, followed by 0.125M glycine quenching for 5 min; (2) hybrid-
ization can be started late in the day and left running overnight to reduce
hands-on time; (3) for MS experiments, lysates were pre-cleared by incubating
with 30 ml washed beads per ml of lysate at 37C for 30 min with shaking (prior
to hybridization, beads were removed twice from lysate using a magnetic
stand); (4) for RNase control, lysates are pooled first and aliquoted into two
equal amounts. 1/1,000 volume of 10 mg/ml Rnase A (Sigma) is added to
the RNase control sample, and both control and non-treated samples are incu-
bated at 37C for 30 min with mixing prior to hybridization steps. This can be
done concurrently with pre-clearing. RNA extraction can be performed from a
small aliquot of post-ChIRP beads as described (Chu et al., 2012). For protein
elution, beadswere collected onmagnetic stand, resuspended in biotin elution
buffer (12.5 mM biotin [Invitrogen], 7.5 mM HEPES [pH 7.5], 75 mM NaCl,
1.5 mM EDTA, 0.15% SDS, 0.075% sarkosyl, and 0.02% Na-Deoxycholate),
mixed at room temperature (r.t.) for 20 min and at 65C for 10 min. Eluent
was transferred to a fresh tube, and beads were eluted again. The two eluents
were pooled, and residual beads were removed again using the magnetic
stand. 25% total volume TCA was added to the clean eluent, and after thor-
ough mixing, proteins were precipitated at 4C overnight. The next day, pro-
teins were pelleted at 16, 000 rcf at 4C for 30 min. Supernatant was carefully
removed from the belly side of tubes, and protein pellets on the spine of tubes
(sometimes invisible at this step) were washed oncewith cold acetone and pel-
leted again at 16,000 rcf at 4C for 5 min, and acetone was removed. Pellets
(much more visible now) were briefly centrifuged again and, after removal of
residual acetone, were left to air-dry for 1 min on bench-top. Proteins are
then immediately solubilized in desired volumes of 13 laemmli sample buffer
(Invitrogen) and boiled at 95C for 30 min with occasional mixing for reverse-
crosslinking. Final protein samples were size-separated in bis-tris SDS-
PAGE gels (Invitrogen) for western blots or MS. See Extended Experimental
Procedures and Table S2 for ChIRP probe design.
Defining Proteins Identified by ChIRP-MS
Potential MS artifacts were first filtered by removing low-confidence protein
hits with fewer than 9 peptides from a single gel-C slice and fewer than 16 total
peptides (a simpler cut-off of >10 peptides from any single gel-C slice was
used for U1/U2). Thereafter, a stringent cut-off of log2 R 3.5 between
experiment and control (R11.3 fold enrichment) is applied to eliminate RNA-
independent background interactions. Specific hits of 7SK ChIRP-MS will be
reported elsewhere. To define specific versus non-specific components of
the Xist lncRNP, ChIRP-MS hits from Xist (differentiated ESC), U1, U2, and
7SK were first ranked based on peptide abundance. Xist-specific interactors
are defined as proteins with Xist ChIRP-MS rank at least twice better than in
ChIRP-MS of U1, U2, and 7SK. Non-specific interactors are proteins that
show rank ratio < 2 in Xist ChIRP versus U1, U2, or 7SK. For the purpose of
comparison, mouse protein names of 7SK and Xist hits were replaced with
their human counterparts (no ambiguity).
Defining Xist-Specific RBPs versus Promiscuous RBPs
Themost enriched protein (most peptide counts in experiment) is ranked 1, the
second most enriched is ranked 2, and so forth. ‘‘Specific interactors’’ for Xist
are defined as proteins that have a rank that is at least 2-fold better than in all
three other ChIRP-MS of U1, U2, or 7SK.
Knockdown Studies
siRNAs and shRNAs are purchased from Dharmacon and Invitrogen. Trans-
fection was performed with nucleofector or RNAiMAX. See Extended Experi-
mental Procedures and Table S5 for full details.
Microscopy
Xist-FISH, Usp9x-FISH, and co-IF are performed with sm-FISH probes with
standard protocol. All other dual-color FISH were essentially performed as
previously described (Chaumeil et al., 2008). See Extended Experimental
Procedures for full protocols and the list of reagents used.
RNA Crosslinking IP and Interaction Studies
Clip-qRTPCR was essentially performed as described (Flynn et al., 2015)
and triple flag-tagged codon-optimized 23 RRM and 33 RRM Spen frag-
ments were used in in vitro interaction studies. See Extended Experimental
Procedures for full details.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, six
figures, and five tables and can be found with this article online at http://dx.
doi.org/10.1016/j.cell.2015.03.025.
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